Metabonomics and its role in drug development and disease diagnosis.
about
Beneficial metabolic effects of 2',3',5'-tri-acetyl-N6- (3-hydroxylaniline) adenosine in the liver and plasma of hyperlipidemic hamstersMetabonomics study of the therapeutic mechanism of Gynostemma pentaphyllum and atorvastatin for hyperlipidemia in ratsMass spectrometry in plant metabolomics strategies: from analytical platforms to data acquisition and processing.Serum Metabolomic Profiles for Breast Cancer Diagnosis, Grading and Staging by Gas Chromatography-Mass Spectrometry.Bile acids conjugation in human bile is not random: new insights from (1)H-NMR spectroscopy at 800 MHzCurrent and future applications of in vitro magnetic resonance spectroscopy in hepatobiliary disease.Advances in NMR-based biofluid analysis and metabolite profilingPharmacogenomics: a systems approach.Glycyrrhizin could reduce ocular hypertension induced by triamcinolone acetonide in rabbits.Amelioration of cognitive impairments in APPswe/PS1dE9 mice is associated with metabolites alteration induced by total salvianolic acid.Metabolomic approaches to phenotype characterization and applications to complex diseases.(1)H NMR-Based Analysis of Serum Metabolites in Monocrotaline-Induced Pulmonary Arterial Hypertensive Rats.Metabolomic analysis and signatures in motor neuron disease.Applications of emerging molecular technologies in glioblastoma multiformeGeneration of hyperpolarized substrates by secondary labeling with [1,1-13C] acetic anhydride.Metabolomics-based methods for early disease diagnosticsProteomic approaches in neuroblastoma: a complementary clinical platform for the future.Differential nitros(yl)ation of blood and tissue constituents during glyceryl trinitrate biotransformation in vivo.Drug-induced autoimmune-like hepatitis.Metabolomics and surgical oncology: Potential role for small molecule biomarkers.Metabolomics in the fields of oncology: a review of recent research.Metabolomics of Rhabdomyosarcoma Cell During Echovirus 30 Infection.Accelerating drug discovery.Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer.Metabonomic profiling of diet-induced hyperlipidaemia in a rat model.Metabolomics based predictive biomarker model of ARDS: A systemic measure of clinical hypoxemia.Inter- and intra-individual variations of urinary endogenous metabolites in healthy male college students using (1)H NMR spectroscopy.Investigation of metabolite alteration in dimethylnitrosamine-induced liver fibrosis by GC-MS.Urinary (1)H-NMR metabonomics study on intervention effects of soya milk in Africans.Metabolomics identifies metabolite biomarkers associated with acute rejection after heart transplantation in rats.High throughput multiorgan metabolomics in the APP/PS1 mouse model of Alzheimer's disease.Rationale, design, methods and baseline characteristics of the Asklepios Study.Beneficial effects of cordycepin on metabolic profiles of liver and plasma from hyperlipidemic hamsters.Metabolic profiling of an alcoholic fatty liver in zebrafish (Danio rerio).A Metabolomic Approach to Predict Breast Cancer Behavior and Chemotherapy Response.Metabolomic profiling of serum in the progression of Alzheimer's disease by capillary electrophoresis-mass spectrometry.Using direct infusion mass spectrometry for serum metabolomics in Alzheimer's disease.Serum Metabolomics Study Based on LC-MS and Antihypertensive Effect of Uncaria on Spontaneously Hypertensive Rats.Metabolomic strategies to identify tissue-specific effects of cardiovascular drugs
P2860
Q28481695-A5061AD8-7C77-4ECF-9C46-45EFC5853869Q28534792-D1D1945E-B181-4FBE-8C67-8E1EA7DD8B9AQ30786453-73914834-5DB7-4EA3-B98D-8881A796903AQ33687106-5EABFF9A-A120-49F4-9DB4-CDA3B48DBF90Q33764381-53D83EC8-1D2C-470B-9292-7C2C7865F638Q33866965-FA39DC45-25FA-4C31-9203-2D7D29406CC1Q34109340-8D966B77-9599-45AC-A3F6-6705995508AAQ34137575-296C375E-9BAF-45C5-9830-DB0DA110BEE4Q35166757-F49681AC-AF25-4594-BA71-7CF9DCF51C82Q36328483-CCE8A6DE-6B41-4546-B458-B2CAB1213427Q36528882-D19A51BB-7504-4C8C-9F03-2E99FF4AFF54Q36555906-A6AF5AA9-9AAA-4C94-8F4A-516AC1682293Q36908588-398800B7-51EC-45E0-80F8-6F9485505F40Q36965370-CC31FC24-F9C4-4BB1-B9F1-5DEC5B280967Q37124121-2654BB8D-D1CE-4925-98FA-E37B7B1F4D02Q37266489-8869AC9B-5EE8-4FBE-A731-C6A159345CD3Q37579903-CE21218E-D53C-4D4E-936A-146FB833688EQ37695567-824B41D5-F895-400A-8FE6-A423C7D84F48Q37843783-1A8F014A-81C7-4D07-81C4-972827693917Q37852648-FC1E9C52-2244-463C-BC41-D90A63D6FB46Q37986476-6BF9EFCF-5E31-4C44-AF69-973D9647C428Q38696258-C026FD56-CC9C-4026-94F4-A106AD2DEB54Q40104889-67A6DE1A-8E7D-4AF5-BFB5-7FEDE59DBE1BQ41134662-B9720C77-5F51-4C76-9E85-63E665C5F38DQ43225856-C998D0E5-EB95-4A77-BCD6-F9197C168ABEQ44003095-8585AE43-8DD0-4941-92EA-A6CDAC75CEFCQ46134363-27DF45C6-5051-470E-B7B2-A9F3661A831AQ46298085-57DCA630-7422-4C8C-BC09-432C99E34F28Q46458218-DAE2F19D-6145-4EF9-AC0C-C37960E47EC2Q47127782-6C28F5E4-D477-4321-AA3F-9EC5793E2F7BQ48349422-E9D7E5B0-76D4-4E54-AD8C-87AEBDC7499EQ48912418-F5C287E7-72B4-42B3-AC00-0A4FDFBAB0BCQ51767543-B4D8CCC3-B96C-48EA-BAEF-64F2694FB35EQ51790158-69448246-42F9-4CE9-9ECB-718D794C0409Q52692110-EC069C66-ABB3-4C07-951F-3675A767380AQ53355934-FC855F9E-72EA-4F14-A47C-2200329B6142Q53356993-9FA89F90-CDE1-4C73-9AEF-350AB08D2163Q55000179-F9B30664-F9DD-4BA3-B7F4-C90024B3E87AQ57012269-ECF3A920-74A4-45C5-BD13-362F39FC7542
P2860
Metabonomics and its role in drug development and disease diagnosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Metabonomics and its role in drug development and disease diagnosis.
@ast
Metabonomics and its role in drug development and disease diagnosis.
@en
type
label
Metabonomics and its role in drug development and disease diagnosis.
@ast
Metabonomics and its role in drug development and disease diagnosis.
@en
prefLabel
Metabonomics and its role in drug development and disease diagnosis.
@ast
Metabonomics and its role in drug development and disease diagnosis.
@en
P2860
P356
P1476
Metabonomics and its role in drug development and disease diagnosis.
@en
P2093
Elaine Holmes
John C Lindon
P2860
P304
P356
10.1586/14737159.4.2.189
P577
2004-03-01T00:00:00Z